【摘要】 企业创新是推动产业结构转型升级，促进经济高质量发展的微观基础。整合制度理论和企业创新管理研究，提出并检验了制度信任影响突破性创新、渐进性创新和新产品绩效的理论框架。基于165家医药企业的实证结果表明，制度信任对突破性创新的正向影响大于其对渐进性创新的正向影响；突破性创新正向影响新产品绩效，渐进性创新与新产品绩效呈U形关系；制度信任显著调节了渐进性创新与新产品绩效之间的关系，但对突破性创新与新产品绩效之间关系的调节作用不显著。通过揭示制度信任在企业创新中的重要作用，研究对从认知视角理解外部正式制度影响创新的深层机制有一定理论贡献。研究结论对企业创新战略制定有重要启示，也对政府进一步完善与医药创新相关的正式制度安排，提升企业创新积极性有指导意义。更多还原

【Abstract】 Firms innovation serves as the microfoundation driving industrial transformation, thereby fostering high-quality economic development. Drawing on institutional theory and firm innovation management literatures, a framework was developed to investigate how institutional trust impacts firms’ radical innovation, incremental innovation, as well as new product performance. Data from 165 pharmaceutical firms reveal that institutional trust more significantly boosts radical innovation than incremental innovation. The findings also indicate that radical innovation positively affects new product performance. However, incremental innovation shows a U-shaped relationship with new product performance. Institutional trust significantly moderates the link between incremental innovation and new product performance, but not between radical innovation and new product performance. By unpacking the important role of institutional trust in firms’ innovation strategy the current study contributes to the understanding of the mechanisms of how external formal institutions influence firm innovation from a cognitive perspective. The research findings provide important insights for firms formulating innovation strategies, and also guide governments in refining formal institutional arrangements related to pharmaceutical innovation, thereby enhancing enthusiasm of firms for innovation.更多还原